Document is current
Any future updates will be listed below
-
Authors
Song, Simin
Liu, Qianmin
Chen, Ruixiang
Chen, Ping
Tao, Min
Li, Siyao
Guo, Liping
Zhu, Xixi
Liu, Yan
Liu, Lu
Sasaguri, Hiroki
Saito, Takashi
Saido, Takaomi C.
Walsh, Dominic M.
Zhang, Zhangjin
Hong, Wei
-
Funding
Funding for this research was provided by:
Shenzhen City's Key Medical Discipline-Department of Traditional Chinese Medicine Brain Disorders (SZXK202302)
National Natural Science Foundation of China (32471010)
Key-Area Research and Development Program of Guangdong Province (2023B0303040004)
Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases (ZDSYS20220304163558001)
Shenzhen Science and Technology Program (JCYJ20220818100802005)
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 8 May 2025
First Online: 24 May 2025
Declarations
:
: All animal experiments this study were performed in accordance with institutional animal care and use guidelines, and were approved by the Institutional Animal Care and Use Committees (IACUC) at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (approved case ID: SIAT-IACUC-20220801-NS-NJBZX-HW-A2091-01). Human specimens were obtained from the Massachusetts ADRC Neuropathology Core, Massachusetts General Hospital and used in accordance with the Partners Institutional Review Board (Protocol: Walsh BWH 2011).
: Not applicable.
: DMW is a former employee of and hold stock in Biogen, he is also a consultant for Acumen, Apellis, BrainQr, Convergen and the Dementia Discovery Fund. The other authors declare that they have no competing interests.
